Participant experiences and recommendations for psychedelic clinical trials and future treatment delivery: a qualitative study with experts by experience from the Psychedelic Participant Advocacy Network
Paper. Seynaeve M, Schneider L, Roullier I et al.. Frontiers in Psychiatry, 14 Oct 2026.
